Porter et al v. Pfizer, Inc. et al

Filing 11

MDL ORDER. CASE TRANSFERRED to District of South Carolina. CASE CLOSED. (Donati, J)

2:14-mn-02502-RMG Date Filed 03/25/15 Entry Number 835 Page 1 of 2
Case MDL No. 2502 Document 557 Filed 03/25/15 Page 1 of 2
UNITED STATES JUDICIAL PANEL
on
MULTIDISTRICT LITIGATION

FILED
Mar 25, 2015

IN RE: LIPITOR (ATORVASTATIN CALCIUM)
MARKETING, SALES PRACTICES AND
PRODUCTS LIABILITY LITIGATION (NO. II)

CLERK, U.S. DISTRICT COURT
EASTERN DISTRICT OF CALIFORNIA

MDL No. 2502

(SEE ATTACHED SCHEDULE)

CONDITIONAL TRANSFER ORDER (CTO 52)

On February 18, 2014, the Panel transferred 42 civil action(s) to the United States District Court for
the District of South Carolina for coordinated or consolidated pretrial proceedings pursuant to 28
U.S.C. § 1407. See 997 F.Supp.2d 1354 (J.P.M.L. 2014). Since that time, 763 additional action(s)
have been transferred to the District of South Carolina. With the consent of that court, all such
actions have been assigned to the Honorable Richard M Gergel.
It appears that the action(s) on this conditional transfer order involve questions of fact that are
common to the actions previously transferred to the District of South Carolina and assigned to Judge
Gergel.
Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict
Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the
District of South Carolina for the reasons stated in the order of February 18, 2014, and, with the
consent of that court, assigned to the Honorable Richard M Gergel.
This order does not become effective until it is filed in the Office of the Clerk of the United States
District Court for the District of South Carolina. The transmittal of this order to said Clerk shall be
stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the
Panel within this 7 day period, the stay will be continued until further order of the Panel.

FOR THE PANEL:

Mar 25, 2015
Jeffery N. Lüthi
Clerk of the Panel

2:14-mn-02502-RMG Date Filed 03/25/15 Entry Number 835 Page 2 of 2
Case MDL No. 2502 Document 557 Filed 03/25/15 Page 2 of 2

IN RE: LIPITOR (ATORVASTATIN CALCIUM)
MARKETING, SALES PRACTICES AND
PRODUCTS LIABILITY LITIGATION (NO. II)

SCHEDULE CTO 52

DIST

DIV.

TAG ALONG ACTIONS

C.A.NO.

CASE CAPTION

15 00561

Porter et al v. Pfizer, Inc. et al

CALIFORNIA EASTERN
CAE

2

MDL No. 2502